High-performance liquid chromatography with ultraviolet detection and protein precipitation as a way of quantitative determination of nilotinib with and without internal standard

Journal of Liquid Chromatography and Related Technologies

Volumn 35, Issue 17, 2012, Pages 2503-2510

  Dziadosz, Marek ^a   Wagner, Marie Christine ^a   Lipka, Daniel B ^a   Fischer, Thomas ^a   Bartels, Heidemarie ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

AMN107; Dasatinib; HPLC DAD; Nilotinib; Tasigna; TKI

Indexed keywords

AMN107; DASATINIB; HPLC-DAD; NILOTINIB; TASIGNA; TKI;

ACETONITRILE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

PROTEINS;

ACETONITRILE; DASATINIB; NILOTINIB;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRECIPITATION; QUANTITATIVE ANALYSIS; SERUM; SOLID PHASE EXTRACTION; STANDARD; ULTRAVIOLET RADIATION;

EID: 84859438665     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826076.2011.636469     Document Type: Article

References (18)

1. Kantarjian, H.; Giles, F.; Wunderle, L.; Bhalla, K.; O'Brien, S.; Wassmann, B.; Tanaka, C.; Manley, P.; Rae, P.; Mietlowski, W.; Bochinski, K.; Hochhaus, A.; Griffin, J. D.; Hoelzer, D.; Albitar, M.; Dugan, M.; Cortes, J.; Alland, L.; Ottmann, O. G. Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome-Positive ALL. N. Engl. J. Med. 2006, 354, 2542-2551. (Pubitemid 43882350)
2. Weisberg, E.; Manley, P. W.; Breitenstein, W.; Brüggen, J.; Cowan-Jacob, S. W.; Ray, A.; Huntly, B.; Fabbro, D.; Fendrich, G.; Hall-Meyers, E.; Kung, A. L.; Mestan, J.; Daley, G. Q.; Callahan, L.; Catley, L.; Cavazza, C.; Mohammed, A.; Neuberg, D.; Wright, R. D.; Gilliland, D. G.; Griffin, J. D. Characterization of AMN107, a Selective Inhibitor of Native and Mutant Bcr-Abl. Cancer Cell 2005, 7, 129-141. (Pubitemid 40248339)
3. Higdon, J. E.; Waddell, J. A.; Solimando, D. A.; Cancer Chemotherapy Update. Hospital Pharm. 2007, 42, 297-300.
4. De Francia, S.; D'Avolio, A.; De Martino, F.; Pirro, E.; Baietto, L.; Siccardi, M.; Simiele, M.; Racca, S.; Saglio, G.; Di Carlo, F.; Di Perri, G. New HPLC-MS Method for the Simultaneous Quantification of the Antileukemia Drugs Imatinib, Dasatinib, and Nilotinib in Human Plasma. J. Chromatogr. B 2009, 877, 1721-1726.
5. Parise, R. A.; Egorin, M. J.; Christner, S. M.; Shah, D. D.; Zhou, W.; Beumer, J. H. A High-Performance Liquid Chromatography-Mass Spectrometry Assay for Quantitation of the Tyrosine Kinase Inhibitor Nilotinib in Human Plasma and Serum. J. Chromatogr. B 2009, 877, 1894-1900.
6. Guetens, G.; Prenen, H.; De Boeck, G.; van Oosterom, A.; Schö ffski, P.; Highley, M.; de Bruijn, E. A. Simultaneous Determination of AMN107 and Imatinib (Gleevec1, Glivec 1,STI571) in Cultured Tumor Cells Using an Isocratic High-Performance Liquid Chromatography Procedure with UV Detection. J. Chromatogr. B 2007, 846, 341-345. (Pubitemid 46149485)
7. Pursche, S.; Ottmann, O. G.; Ehninger, G.; Schleyer, E. High-Performance Liquid Chromatography Method with Ultraviolet Detection for the Quantification of the BCR-ABL Inhibitor Nilotinib (AMN107) in Plasma, Urine, Culture Medium and Cell Preparations. J. Chromatogr. B 2007, 852, 208-216. (Pubitemid 46830984)
8. Miura, M.; Takahashi, N.; Sawada, K. High-Performance Liquid Chromatography with Solid-Phase Extraction for the Quantitative Determination of Nilotinib in Human Plasma. Biomed. Chromatogr. 2010, 24, 789-793.
9. Dziadosz, M.; Bartels, H. Imatinib Quantification in Human Serum for Clinical Purposes using High-performance Liquid Chromatography with a Diode Array Detector. Acta Chim. Slov. 2011, 58, 347-350.
10. Zeng, W.; Xu, Y.; Constanzer, M.; Woolf, E. J. Determination of Sitagliptin in Human Plasma Using Protein Precipitation and Tandem Mass Spectrometry. J. Chromatogr. B 2010, 878, 1817-1823.
11. Xiong, X.; Yang, L.; Zhai, S. Validation of a Rapid and Simple LC-MS=MS Method to Determine Trimetazidine in Rat Plasma. J. Liquid Chromatogr. Rel. Technol. 2011, 34, 1645-1653.
12. Ahmad, L.; Iqbal, Z.; Nazir, S.; Shah, Y.; Khan, A.; Khan, M. I.; Nasir, F.; Khan, A. Optimization and Validation of HPLC-UV Method for Simultaneous Determination of Omeprazole and Its Metabolites in Human Plasma: Effects of Various Experimental Conditions and Parameters. J. Liquid Chromatogr. Rel. Technol. 2011, 34, 1488-1501.
13. Macek, J.; Klíma, J.; Ptáček, P. Rapid Determination of Valsartan in Human Plasma by Protein Precipitation and High-Performance Liquid Chromatography. J. Chromatogr. B 2006, 832, 169-172. (Pubitemid 43213025)
14. Uchoa, F. D. T.; Haas, S. E.; Junior, L. B.; Pigatto, M. C.; Lima, M. C. A.; Galdino, S. L.; Pitta, I. R.; Costa, T. D. Development and Validation of an LC-MS=MS Method for the Pre-Clinical Pharmacokinetic Investigation of the Anticancer Candidate AC04 in Rodents. J. Liquid Chromatogr. Rel. Technol. 2011, 34, 744-752.
15. Choi, S. J.; Ryu, J. H.; Lee, H. W.; Lee, M. J.; Seo, J. H.; Tak, S. K.; Lee, K. T. Rapid and Simple Method for Determination of Cephradine in Human Plasma Using Liquid Chromatography- Tandem Mass Spectrometry (LC-MS=MS): Application to the Bioequivalence Study. J. Chromatogr. B 2009, 877, 4059-4064.
16. Vlase, L.; Muntean, D.; Cuciureanu, M.; Cuciureanu, R.; Gocan, S. High-Throughput Determination of Linezolid in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry. J. Liquid Chromatogr. Rel. Technol. 2011, 34, 591-600.
17. Du, L.; Miller-Stein, C. M.; Valesky, R. J.; Martucci, A. N.; Woolf, E. J. A Flexible and High Throughput Liquid Chromatography-Tandem Mass Spectrometric Assay for the Quantitation of Telcagepant in Human Plasma. J. Chromatogr. B 2009, 877, 1465-1471.
18. Kasawar, G.; Razzak, M.; Zaheer, Z.; Farooqui, M. Validated RP-LC-MS=MS Method for the Simultaneous Determination of Allopurinol and Its Major Metabolite, Oxypurinol, in Human Plasma. J. Liquid Chromatogr. Rel. Technol. 2011, 34, 26-37.